Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Bruker CorpBRKR28.772.704.7520.9419.73%2.22%40.58$61.23$160.8818,851$57.82

Detail of Bruker Corp

 
CEO
Dr. Frank H. Laukien Ph.D.
Employees
7765
Industry
Medical Devices
Sector
Healthcare
Market cap
$9B

Company details

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OTH
OI
OIE
PI
TAX
NI
Revenue (Rev)
$3.24B
Cost of goods (CoG)
-$1.65B
Gross profit (GP)
$1.59B
Operating expense (OE)
-$1.22B
Research and development (R&D)
-$355.60M
General and administrative (G&A)
-$866.30M
Other (OTH)
-$1.70M
Operating income (OI)
$364.60M
Other income expense (OIE)
-$54.40M
Pretax income (PI)
$391.70M
Tax (TAX)
-$87.80M
Net income (NI)
$304.50M
Bruker Corp
BRKR • XNGS • US
$57.82
-15.82 (-21.49%)
Stock vs Industry average
  • Industry average

Dividend yield
0.35%
Trailing annual dividend rate
$0.20
Payout ratio
9.66%
EPS
$2.01
Margin profit
9.41%
52 week low
$48.205002
52 week high
$94.235001
50-day simple moving average
$57.34
200-day simple moving average
$61.23
Percent held by insiders
31.92%
Percent held by institutions
79.84%
Dividend yield
0.34%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
BRKR -21.67%
eps change
BRKR -55.00%